GGrantIndex
Sort

78,016 grants matching breast cancer

Risk Prediction for Breast Cancer: A Tissue-Based Strategy

$620,705
Lynn C. Hartmann · Mayo Clinic Rochester · R01 · FY2008 · CA

Multi-site adaptive trial of a technology-based, EHR-integrated physical activity intervention in breast and endometrial cancer survivors

$620,702
Lisa Anne Cadmusbertram · University Of Wisconsin-Madison · R37 · FY2022 · CA

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology

$620,698
Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA

Identifying senescence and immune biomarkers predictive of benefit to combined CDK4 and checkpoint blockade inhibition in patients with dedifferentiated liposarcoma

$620,672
Sandra P D'angelo · Sloan-Kettering Inst Can Research · R01 · FY2024 · FD

(PQC2)High-content Pathology with Confocal Microscope Arrays

$620,631
Olav Solgaard · Stanford University · R01 · FY2016 · CA

EFFECTS OF NUCLEAR PARATHYROID HORMONE-RELATED PROTEIN SIGNALING IN BREAST CANCER

$620,626
Yale Univ · · FY2010 · Department of the Army

Genetic Alterations That Initiate Follicular Thyroid Carcinogenesis

$620,607
Charis Eng · Ohio State University · P01 · FY2009 · CA

DELINEATING THE EVOLUTION AND ECOLOGY OF CHEMORESISTANCE IN BREAST CANCER WITH SINGLE CELL GENOMICS

$620,575
Nicholas Navin · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

DELINEATING THE EVOLUTION AND ECOLOGY OF CHEMORESISTANCE IN BREAST CANCER WITH SINGLE CELL GENOMICS

$620,575
Nicholas Navin · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression

$620,565
Heide L Ford · University Of Colorado Denver · R01 · FY2018 · CA

Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression

$620,565
Heide L Ford · University Of Colorado Denver · R01 · FY2021 · CA

Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression

$620,565
Heide L Ford · University Of Colorado Denver · R01 · FY2020 · CA

Tunneling Nanotube Inhibitors for Cancer Immunotherapy

$620,466
Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2024 · CA

DECISIONS &OUTCOMES OF BRCA 1/2 TEST FOR BREAST PATIENT

$620,444
Georgetown University · R01 · FY2000 · CA

Combined Methylation and Mutation to Predict Response to PARP Inhibitors

$620,421
Elizabeth Mary Swisher · University Of Washington · R01 · FY2021 · CA

Patient Navigation 2.0: Addressing the Challenge of Scaling Navigation through Checklist-based Implementation

$620,419
Melissa A. Simon · Northwestern University At Chicago · R01 · FY2020 · CA

A Randomized Trial to Minimize Non-Response to Aerobic Training in Operable Breast Cancer

$620,371
Jessica Scott · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA

Quantitative volumetric ultrasonic and photoacoustic tomography

$620,341
Katherine W Ferrara · Stanford University · R01 · FY2024 · CA

Optimizing Individualized and Adaptive mHealth Interventions via Control Systems Engineering Methods

$620,335
Eric Hekler · University Of California, San Diego · R01 · FY2022 · CA

A Conversation Aid on Mammography Screening to Support Shared Decision Making between Clinicians and Women Aged 75 and Older

$620,309
Mara A Schonberg · Beth Israel Deaconess Medical Center · R01 · FY2024 · AG

Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials

$620,305
Raymond F Muzic · Case Western Reserve University · R01 · FY2015 · CA

Caregiver Coping Skills training for Lung Cancer

$620,301
Duke University · R01 · FY2002 · CA

Developing DOSI Technology for Monitoring Response To Breast Cancer Chemotherapy

$620,268
Bruce J Tromberg · University Of California-Irvine · R01 · FY2014 · CA

A RCT TO PROMOTE MAMMOGRAPHY ADHERENCE AMONG CHINESE IMMIGRANT WOMEN

$620,235
Judy Huei-Yu Wang · Georgetown University · R01 · FY2011 · CA

Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention

$620,234
Jennifer Barsky Reese · Research Inst Of Fox Chase Can Ctr · R01 · FY2021 · CA